Durata Therapeutics - Ownership and Business Overview

Life ScienceCompany

Durata Therapeutics Ownership

Who owns Durata Therapeutics?

Durata Therapeutics is owned by Allergan. It was acquired on October 6, 2014.

Durata Therapeutics Business Overview

Where is Durata Therapeutics headquartered?

Durata Therapeutics is headquartered in Chicago, Illinois.

How many employees does Durata Therapeutics have?

Durata Therapeutics has 206 employees.

What sector is Durata Therapeutics in?

Durata Therapeutics is a life science company.

When was Durata Therapeutics founded?

Durata Therapeutics was founded in 2009.

Life Science M&A Summary in 2014

Out of 60 sectors in the Mergr database, life science ranked 9 in number of deals in 2014. The largest life science acquisition in 2014 was InterMune - which was acquired by Roche Holding AG for $8.3B.

Join Mergr to view all 237 acquisitions of life science companies in 2014, including 22 acquisitions by private equity firms, and 215 by strategics.

Durata Therapeutics, Inc.

200 Sourth Wacker Drive Suite 2550,
Chicago, Illinois 60606
United States,
(312) 219-7000
www.duratatherapeutics.com

Durata Therapeutics, Inc. is a pharmaceutical company focused on the development and commercialization of novel therapeutics for patients with infectious diseases and acute illnesses.


 Subscribe to unlock this and 209,235
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 202K M&A Transactions
  • 205K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.